Honoured haematologist and HIV pioneer fears he won t see action from glacial Pharmac in his lifetime stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
03/02/2021
Watch: Ken Romeril on The AM Show. Credits: Video - The AM Show; Image - Getty
A haematologist is calling for increased funding towards blood cancer treatments in New Zealand, arguing there is a lack of awareness regarding the diseases that kill an estimated 800 Kiwis each year.
Ken Romeril, a haematologist with a specialist interest in myeloma, is the chief executive of Myeloma New Zealand, a non-profit organisation that focuses specifically on multiple myeloma and improving the lives of affected patients.
Related News
He believes that a new report, The State of Cancer in New Zealand in 2020 - released by Te Aho o Te Kahu, the Cancer Control Agency, on Tuesday - failed to sufficiently address blood cancers, which currently affect around 26,000 New Zealanders.
Erratum
PDF Download
Consensus statement on the treatment of transplant-eligible patients with newly diagnosed multiple myeloma in New Zealand
Nicole Chien, Ken Romeril, Bart Baker, Hugh Goodman, Henry Chan, on behalf of the Myeloma Interest Group
Published: 18 December 2020 (Vol 133 No 1527)
In Table 1, the recommended dosage of Bortezomib in the VTD induction regimen was incorrectly reported as 1.3mg/m2. The correct recommended dosage is 1.5mg/m2.
This error was resolved online and in the PDF on 13 January 2021.
Summary